Shanghai Yizhong Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 688091.SS

Shanghai Yizhong Pharmaceutical Co., Ltd. Interest Coverage Ratio for the year ending December 31, 2023: 582.41

Shanghai Yizhong Pharmaceutical Co., Ltd. Interest Coverage Ratio is 582.41 for the year ending December 31, 2023, a -98.79% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.

Shanghai Yizhong Pharmaceutical Co., Ltd. Interest Coverage Ratio for the year ending December 31, 2022 was 48,036.40, a 326,077.48% change year over year.
Shanghai Yizhong Pharmaceutical Co., Ltd. Interest Coverage Ratio for the year ending December 31, 2021 was -14.74, a 99.17% change year over year.
Shanghai Yizhong Pharmaceutical Co., Ltd. Interest Coverage Ratio for the year ending December 31, 2020 was -1,782.26, a 96.21% change year over year.
Shanghai Yizhong Pharmaceutical Co., Ltd. Interest Coverage Ratio for the year ending December 31, 2019 was -47,047.42.

Key data

Date	Interest Coverage Ratio	Debt to Equity Ratio	Interest Expense To Sales	Inventory Turnover Ratio

Shanghai Stock Exchange: 688091.SS

Shanghai Yizhong Pharmaceutical Co., Ltd.

CEO	Mr. Jingsong Zhou
IPO Date	Sept. 9, 2021
Location	China
Headquarters	No.79 Renqi Road
Employees	304
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the development of anti-tumor drugs and related products in China. It develops a dosage form of paclitaxel, an anti-tumor chemotherapeutic. The company was founded in 2009 and is based in Shanghai, China.

Key trends

Past 5 years